Quantifying the heritability of glioma using genome-wide complex trait analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kinnersley, Ben ^a   Mitchell, Jonathan S ^a   Gousias, Konstantinos ^b   Schramm, Johannes ^b   Idbaih, Ahmed ^c,d   Labussière, Marianne ^c   Marie, Yannick ^c   Rahimian, Amithys ^c,e   Wichmann, H Erich ^f,g,h   Schreiber, Stefan ^i,j   Hoang Xuan, Khe ^c,d,e   Delattre, Jean Yves ^c,d,e   Nöthen, Markus M ^k   Mokhtari, Karima ^d   Lathrop, Mark ^l,m   Bondy, Melissa ⁿ   Simon, Matthias ^b   Sanson, Marc ^c,d,e   Houlston, Richard S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c SORBONNE UNIVERSITÉ   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Onconeurotek   (France)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

ⁱ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^j UNIVERSITY OF KIEL   (Germany)

^k UNIVERSITY OF BONN   (Germany)

^l FONDATION JEAN DAUSSET CEPH   (France)

^m MCGILL UNIVERSITY   (Canada)

ⁿ BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BRAIN TUMOR; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GLIOMA; HUMAN; MIDDLE AGED; PATHOLOGY; QUANTITATIVE TRAIT; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BRAIN NEOPLASMS; GENOME-WIDE ASSOCIATION STUDY; GLIOMA; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; RETROSPECTIVE STUDIES;

EID: 84949009442     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17267     Document Type: Article

References (45)

1. Bondy, M. L. et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113, 1953-68 (2008).
2. Louis, D. N. et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97-109 (2007).
3. Sanson, M. et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27, 4150-4 (2009).
4. Weller, M. et al. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J Clin Oncol 27, 5743-50 (2009).
5. Ostrom, Q. T. et al. The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol 16, 896-913 (2014).
6. Hodgson, S. V., Maher, E. R. & Hodgson, S. A practical guide to human cancer genetics, (Springer, 1999).
7. Hemminki, K., Tretli, S., Sundquist, J., Johannesen, T. B. & Granstrom, C. Familial risks in nervous-system tumours: a histologyspecific analysis from Sweden and Norway. Lancet Oncol 10, 481-8 (2009).
8. Shete, S. et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41, 899-904 (2009).
9. Sanson, M. et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 20, 2897-904 (2011).
10. Wrensch, M. et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41, 905-8 (2009).
11. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 88, 76-82 (2011).
12. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. Genome-wide complex trait analysis (GCTA): methods, data analyses, and interpretations. Methods Mol Biol 1019, 215-36 (2013).
13. Yang, J. et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet 43, 519-25 (2011).
14. Golan, D., Lander, E. S. & Rosset, S. Measuring missing heritability: Inferring the contribution of common variants. Proceedings of the National Academy of Sciences 111, E5272-E5281 (2014).
15. Hunter, D. J. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39, 870-4 (2007).
16. Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39, 645-9 (2007).
17. Hercberg, S. et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164, 2335-42 (2004).
18. Wichmann, H. E., Gieger, C., Illig, T. & Group, M. K. S. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67 Suppl 1, S26-30 (2005).
19. Holle, R., Happich, M., Lowel, H., Wichmann, H. E. & Group, M. K. S. KORA-a research platform for population based health research. Gesundheitswesen 67 Suppl 1, S19-25 (2005).
20. Holle, R., Happich, M., Lowel, H. & Wichmann, H. E. KORA-a research platform for population based health research. Gesundheitswesen 67 Suppl 1, S19-25 (2005).
21. Wichmann, H. E., Gieger, C. & Illig, T. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67 Suppl 1, S26-30 (2005).
22. Krawczak, M. et al. PopGen: population-based recruitment of patients and controls for the analysis of complex genotypephenotype relationships. Community Genet 9, 55-61 (2006).
23. Lee, S. H., Wray, N. R., Goddard, M. E. & Visscher, P. M. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet 88, 294-305 (2011).
24. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-75 (2007).
25. Yang, J. et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 42, 565-9 (2010).
26. Lu, Y. et al. Most common 'sporadic' cancers have a significant germline genetic component. Hum Mol Genet 23, 6112-8 (2014).
27. Lee, S. H. et al. Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis. Hum Mol Genet 22 832-41 (2013).
28. Ostrom, Q. T. et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. Neuro-Oncology 16, iv1-iv63 (2014).
29. Surveillance Epidemiology and End Results (SEER) Program. DevCan database: "SEER 18 Incidence and Mortality, -., with Kaposi Sarcoma and Mesothelioma". National Cancer Institute, DCCPS, Surveillace Research Program, Surveillance SYstems Branch, released August 2014, based on the November 2013 submission. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).
30. Lee, S. H., Yang, J., Goddard, M. E., Visscher, P. M. & Wray, N. R. Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood. Bioinformatics 28, 2540-2 (2012).
31. Golan, D., Lander, E. S. & Rosset, S. Measuring missing heritability: inferring the contribution of common variants. Proc Natl Acad Sci USA 111, E5272-81 (2014).
32. Higgins, J. P. T., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses, 557-560 (2003).
33. Ng, S. B. et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461, 272-6 (2009).
34. Cooper, G. M. et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 15, 901-13 (2005).
35. Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46, 310-5 (2014).
36. Kent, W. J. et al. The human genome browser at UCSC. Genome Research 12, 996-1006 (2002).
37. Pritchard, J. K. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 69, 124-37 (2001).
38. Malmer, B. et al. Genetic epidemiology of glioma. Br J Cancer 84 429-34 (2001).
39. De Andrade, M. et al. Segregation analysis of cancer in families of glioma patients. Genet Epidemiol 20, 258-70 (2001).
40. Speed, D., Hemani, G., Johnson, M. R. & Balding, D. J. Improved heritability estimation from genome-wide SNPs. Am J Hum Genet 91, 1011-21 (2012).
41. Enciso-Mora, V. et al. Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br J Cancer 108, 2178-85 (2013).
42. Malmer, B. et al. GLIOGENE an International Consortium to Understand Familial Glioma. Cancer Epidemiol Biomarkers Prev 16, 1730-4 (2007).
43. Ohgaki, H. & Kleihues, P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170, 1445-53 (2007).
44. Nobusawa, S., Watanabe, T., Kleihues, P. & Ohgaki, H. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15, 6002-7 (2009).
45. Erbel, R. et al. Die Heinz Nixdorf Recall Studie. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 55, 809-815 (2012).